Myriad Genetics Precise Oncology Solutions
Myriad Genetics announced the launch of Precise Oncology Solutions, a new service through which oncologists can order its BRACAnalysis CDx and MyChoice CDx; its MyRisk Hereditary Cancer Test; and the Precise Tumor Molecular Profile Test, which is performed at a CLIA-certified lab operated by Intermountain Healthcare. Myriad and Intermountain, both headquartered in Salt Lake City, Utah, have been working on this combined offering for the past year to streamline oncologists' access to next-generation sequencing-based germline and somatic analysis, which can inform patients' inherited cancer risks and expand their personalized treatment opportunities. Doctors can order all the tests offered through this service and receive results via a new online portal. Myriad also said it will share with researchers deidentified genomic and clinical data from patients tested through this service within a new Precise Treatment Registry, powered by DNANexus' bioinformatics platform.